Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of murine chlamydia in preparation of anti-ulcerative colitis medicine

A mouse Chlamydia, anti-ulcer technology, applied in the field of biomedicine, can solve rare problems such as digestive system

Active Publication Date: 2021-10-01
NANHUA UNIV
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the research on chlamydia mainly focuses on its pathogenicity, especially the research on the urogenital tract and respiratory system, but the research on the digestive system is very rare, and the effect of chlamydia on the intestinal tract and related molecular mechanisms are rarely related Literature report

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of murine chlamydia in preparation of anti-ulcerative colitis medicine
  • Application of murine chlamydia in preparation of anti-ulcerative colitis medicine
  • Application of murine chlamydia in preparation of anti-ulcerative colitis medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0015] 1. Chlamydia murine has anti-ulcerative colitis effect

[0016] (1) Growth of Chlamydia murine (CM) in the intestinal tract of C57BL / 6J wild-type mice (Table 1)

[0017] Table 1. Growth of CM in the intestine of wild-type mice (log10 )

[0018]

[0019] Note: ND means not detected

[0020] After Chlamydia murine infects C57BL / 6J wild-type mice by intragastric administration, the anus test was used to detect the growth of the intestinal lingloplasma. The results of IFA showed that the growth of Chlamydia in the intestines of wild-type mice was relatively stable. The role of anti-ulcerative colitis lays the groundwork.

[0021] (2) Chlamydia murine (CM) inhibited DSS-induced weight loss in C57BL / 6J wild-type mice ( figure 1 )

[0022] Wild-type murine Chlamydia (G13.32.1) was intragastrically infected (intragastric infection, i.g.) C57BL / 6J wild-type mice were given 3.5% DSS drinking water at 29 days after infection, and continued for 5 days. The results showed t...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention shows by experiments that mouse Chlamydia (Chlamydia muridarum, CM) can antagonize the wild-type mouse ulcerative colitis induced by dextran sulfate sodium (Dextran Sulfate Sodium, DSS), suggesting that CM has anti-ulcerative colitis It can be used to prepare anti-ulcerative colitis drugs.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to the application of murine chlamydia in the preparation of anti-ulcerative colitis medicine. Background technique [0002] Inflammatory bowel disease (Inflammatory Bowel Disease, IBD) is a common chronic inflammatory disease of the digestive system. Its clinical symptoms mainly include abdominal pain, diarrhea, and blood in the stool, and extraintestinal clinical manifestations such as skin, joints, eyes, bones, and liver and bile ducts often occur. The pathogenesis of IBD is complex, with multiple stages of pathogenesis, unclear etiology, easy recurrence, easy cancer and difficult to cure, so it is listed by the World Health Organization as one of the modern intractable diseases. Epidemiological surveys found that the incidence of the disease has been increasing year by year in recent years, which seriously endangers people's health and quality of life. Although ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C12N1/20A61P1/04
CPCA61K35/74A61P1/04
Inventor 贺庆芝
Owner NANHUA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products